Yogik Onky Silvana Wijaya

发表

High Concentration or Combined Treatment of Antisense Oligonucleotides for Spinal Muscular Atrophy Perturbed SMN2 Splicing in Patient Fibroblasts

Y. Takeshima, H. Nishio, Toshio Saito, 2022, Genes.

Combination of Capsaicin and Vitamin E Increase HDL and Decrease LDL Levels in Hypercholesterolemic Rats

Yogik Onky Silvana Wijaya, A. Farmawati, Daniel Agriva Tamba, 2014 .

A Novel System for Spinal Muscular Atrophy Screening in Newborns: Japanese Pilot Study

H. Nishio, A. Takeuchi, K. Tobita, 2019, International journal of neonatal screening.

Dried Blood Spot Screening System for Spinal Muscular Atrophy with Allele-Specific Polymerase Chain Reaction and Melting Peak Analysis.

Masako Kato, H. Nishio, Mawaddah Ar Rochmah, 2021, Genetic testing and molecular biomarkers.

Clinical phenotypes of spinal muscular atrophy patients with hybrid SMN gene

Y. Takeshima, H. Nishio, Toshio Saito, 2020, Brain and Development.

Stability and Oligomerization of Mutated SMN Protein Determine Clinical Severity of Spinal Muscular Atrophy

Y. Takeshima, H. Nishio, Mawaddah Ar Rochmah, 2022, Genes.

Intron-retained transcripts of the spinal muscular atrophy genes, SMN1 and SMN2

H. Nishio, M. Matsuo, N. Harahap, 2018, Brain and Development.

PCR-Based Screening of Spinal Muscular Atrophy for Newborn Infants in Hyogo Prefecture, Japan

Y. Takeshima, H. Nishio, Toshio Saito, 2022, Genes.

Spinal Muscular Atrophy: Diagnosis, Incidence, and Newborn Screening in Japan

Y. Takeshima, H. Nishio, Toshio Saito, 2021, International journal of neonatal screening.

Nested PCR Amplification Secures DNA Template Quality and Quantity in Real-time mCOP-PCR Screening for SMA.

Y. Takeshima, H. Nishio, N. Harahap, 2019, The Kobe journal of medical sciences.

Detection of Spinal Muscular Atrophy Patients Using Dried Saliva Spots

Y. Takeshima, H. Nishio, Toshio Saito, 2021, Genes.

Phenotypes of SMA patients retaining SMN1 with intragenic mutation

Y. Takeshima, H. Nishio, Toshio Saito, 2021, Brain and Development.

Assessment of Spinal Muscular Atrophy Carrier Status by Determining SMN1 Copy Number Using Dried Blood Spots

H. Nishio, N. Harahap, D. K. Nurputra, 2020, International journal of neonatal screening.

Newborn Screening for Spinal Muscular Atrophy: DNA Preparation from Dried Blood Spot and DNA Polymerase Selection in PCR.

Y. Takeshima, H. Nishio, Toshio Saito, 2019, The Kobe journal of medical sciences.

Glycogen Storage Disease Type Ia Screening Using Dried Blood Spots on Filter Paper: Application of COP-PCR for Detection of the c.648G>T G6PC Gene Mutation.

H. Nishio, Emma Tabe Eko Niba, H. Awano, 2021, The Kobe journal of medical sciences.

DBS Screening for Glycogen Storage Disease Type 1a: Detection of c.648G>T Mutation in G6PC by Combination of Modified Competitive Oligonucleotide Priming-PCR and Melting Curve Analysis

Y. Takeshima, H. Nishio, Emma Tabe Eko Niba, 2021, International journal of neonatal screening.

Phosphoethanolamine Elevation in Plasma of Spinal Muscular Atrophy Type 1 Patients.

H. Hara, H. Nishio, N. Harahap, 2020, The Kobe journal of medical sciences.

Correction: Noguchi et al. PCR-Based Screening of Spinal Muscular Atrophy for Newborn Infants in Hyogo Prefecture, Japan. Genes 2022, 13, 2110

Y. Takeshima, H. Nishio, A. Takeuchi, 2023, Genes.